Results 191 to 200 of about 18,494 (211)

How to: Clostridioides difficile infection in children

Clinical Microbiology and Infection, 2022
Clostridioides difficile infections (CDI) are traditionally attributed to an older adult patient group but children can also be affected. Although the causative pathogen is the same in both populations, the management of CDI may differ.To discuss the current literature on CDI in the paediatric population and to provide CDI diagnostics and treatment ...
Marcela, Krutova, de Meij, G J Tim, Fidelma, Fitzpatrick, Richard, Drew J, Mark, Wilcox H, Ed, Kuijper J   +5 more
openaire   +6 more sources

Diagnosis and treatment of Clostridioides difficile infection

Medicina Clínica (English Edition), 2020
Clostridioides difficile is the main cause of healthcare-associated diarrhoea in adults. The incidence of C.difficile infection (CDI) has increased in recent years. The risk of recurrence of CDI is 15%-25% in a first episode and this risk is increased in subsequent episodes.
Gema Fernández-Rivas, Nieves Sopena, Lourdes Mateu   +2 more
openaire   +2 more sources

Clostridioides difficile infection: an emerging zoonosis?

Expert Review of Anti-infective Therapy, 2021
Clostridioides difficile (C. difficile) infection (CDI) is the most common cause of antibiotic-associated diarrhea and one of the common infections in healthcare facilities. In recent decades, there has been an emerging threat of community-acquired CDI (CA-CDI). Environmental transmission of C.
Yuan Pin Hung, Wen Chien Ko, Chin Shiang Tsai, Jen Chieh Lee, Po-Ren Hsueh, Ling Shan Syue   +5 more
openaire   +3 more sources

Prevention of Infection due to Clostridium (Clostridioides) difficile

Infectious Disease Clinics of North America, 2021
Clostridium (Clostridioides) difficile infection (CDI) causes significant morbidity and mortality in the United States every year. Prevention of CDI is difficult because of spore durability and requires implementation of multipronged strategies. Two categories of prevention strategies are infection control and prevention and risk factor reduction. Hand
Amar Krishna, Teena Chopra
openaire   +3 more sources

Clostridioides difficile infection diagnosis

Annales de Biologie Clinique
Clostridioides difficile is a Gram-positive, spore-forming anaerobic enteropathogen responsible for a wide spectrum of clinical diseases ranging from mild diarrhoea to pseudomembranous colitis. It is the first cause of healthcare-associated diarrhoeas, but community-associated Clostridioides difficile infections (CDI) are increasingly reported in ...
Jeanne, Couturier, Muriel, Ehmig, Imane, Mostaghat, Frédéric, Barbut   +3 more
openaire   +2 more sources

Clostridioides difficile infections among healthcare workers

American Journal of Infection Control, 2020
Health care workers (HCWs) are constantly exposed to patients with Clostridiodes difficile infection (CDI) although their risk developing infection is unknown. We designed a retrospective comparative study including HCWs with CDI and 2 comparator groups with a 1:2 ratio: HCWs without CDI and admitted patients with CDI.
Gloria M. Aguirre-García, Elvira Garza-González, Rayo Morfin-Otero, Adrián Camacho-Ortiz   +3 more
openaire   +3 more sources

Ridinilazole for the treatment ofClostridioides difficileinfection

Expert Opinion on Investigational Drugs, 2019
Ridinilazole is a novel antibiotic being developed for the treatment of Clostridioides difficile infection (CDI). Ridinilazole has completed two phase II trials and phase III trials which are denoted Ri-CoDIFy 1 and 2, are planned (ClinicalTrials.gov identifiers: NCT03595553 and NCT03595566).
Bradley T. Endres, Anne J Gonzales-Luna, Kevin W. Garey, Eugénie Bassères, Travis J Carlson   +4 more
openaire   +3 more sources